Literature DB >> 8780787

A fast flexible docking method using an incremental construction algorithm.

M Rarey1, B Kramer, T Lengauer, G Klebe.   

Abstract

We present an automatic method for docking organic ligands into protein binding sites. The method can be used in the design process of specific protein ligands. It combines an appropriate model of the physico-chemical properties of the docked molecules with efficient methods for sampling the conformational space of the ligand. If the ligand is flexible, it can adopt a large variety of different conformations. Each such minimum in conformational space presents a potential candidate for the conformation of the ligand in the complexed state. Our docking method samples the conformation space of the ligand on the basis of a discrete model and uses a tree-search technique for placing the ligand incrementally into the active site. For placing the first fragment of the ligand into the protein, we use hashing techniques adapted from computer vision. The incremental construction algorithm is based on a greedy strategy combined with efficient methods for overlap detection and for the search of new interactions. We present results on 19 complexes of which the binding geometry has been crystallographically determined. All considered ligands are docked in at most three minutes on a current workstation. The experimentally observed binding mode of the ligand is reproduced with 0.5 to 1.2 A rms deviation. It is almost always found among the highest-ranking conformations computed.

Mesh:

Substances:

Year:  1996        PMID: 8780787     DOI: 10.1006/jmbi.1996.0477

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  484 in total

1.  The sensitivity of the results of molecular docking to induced fit effects: application to thrombin, thermolysin and neuraminidase.

Authors:  C W Murray; C A Baxter; A D Frenkel
Journal:  J Comput Aided Mol Des       Date:  1999-11       Impact factor: 3.686

2.  Deciphering common failures in molecular docking of ligand-protein complexes.

Authors:  G M Verkhivker; D Bouzida; D K Gehlhaar; P A Rejto; S Arthurs; A B Colson; S T Freer; V Larson; B A Luty; T Marrone; P W Rose
Journal:  J Comput Aided Mol Des       Date:  2000-11       Impact factor: 3.686

3.  Ligand-receptor docking with the Mining Minima optimizer.

Authors:  L David; R Luo; M K Gilson
Journal:  J Comput Aided Mol Des       Date:  2001-02       Impact factor: 3.686

4.  The binding conformation of Taxol in beta-tubulin: a model based on electron crystallographic density.

Authors:  J P Snyder; J H Nettles; B Cornett; K H Downing; E Nogales
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-17       Impact factor: 11.205

5.  MCDOCK: a Monte Carlo simulation approach to the molecular docking problem.

Authors:  M Liu; S Wang
Journal:  J Comput Aided Mol Des       Date:  1999-09       Impact factor: 3.686

6.  DREAM++: flexible docking program for virtual combinatorial libraries.

Authors:  S Makino; T J Ewing; I D Kuntz
Journal:  J Comput Aided Mol Des       Date:  1999-09       Impact factor: 3.686

7.  The maximal affinity of ligands.

Authors:  I D Kuntz; K Chen; K A Sharp; P A Kollman
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-31       Impact factor: 11.205

8.  Comparison of two implementations of the incremental construction algorithm in flexible docking of thrombin inhibitors.

Authors:  R M Knegtel; D M Bayada; R A Engh; W von der Saal; V J van Geerestein; P D Grootenhuis
Journal:  J Comput Aided Mol Des       Date:  1999-03       Impact factor: 3.686

9.  Computer based screening of compound databases: 1. Preselection of benzamidine-based thrombin inhibitors.

Authors:  T Fox; E E Haaksma
Journal:  J Comput Aided Mol Des       Date:  2000-07       Impact factor: 3.686

10.  Identification of ligands for RNA targets via structure-based virtual screening: HIV-1 TAR.

Authors:  A V Filikov; V Mohan; T A Vickers; R H Griffey; P D Cook; R A Abagyan; T L James
Journal:  J Comput Aided Mol Des       Date:  2000-08       Impact factor: 3.686

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.